Bank of Montreal’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.73M | Sell |
777,938
-4,825
| -0.6% | -$21.2K | ﹤0.01% | 1481 |
|
|
2026
Q1 | $3.52M | Buy |
782,763
+16,107
| +2% | +$70.4K | ﹤0.01% | 1450 |
|
|
2025
Q4 | $3.69M | Buy |
766,656
+1,393
| +0.2% | +$6.26K | ﹤0.01% | 1449 |
|
|
2025
Q3 | $3.47M | Buy |
765,263
+164,833
| +27% | +$605K | ﹤0.01% | 1451 |
|
|
2025
Q2 | $1.86M | Buy |
600,430
+19,350
| +3% | +$64.3K | ﹤0.01% | 1612 |
|
|
2025
Q1 | $2.03M | Buy |
581,080
+125,200
| +27% | +$418K | ﹤0.01% | 1503 |
|
|
2024
Q4 | $1.49M | Buy |
455,880
+15,567
| +4% | +$57.3K | ﹤0.01% | 1681 |
|
|
2024
Q3 | $1.69M | Buy |
440,313
+85,500
| +24% | +$328K | ﹤0.01% | 1778 |
|
|
2024
Q2 | $1.1M | Buy |
354,813
+20,548
| +6% | +$61.6K | ﹤0.01% | 1973 |
|
|
2024
Q1 | $872K | Sell |
334,265
-18,000
| -5% | -$46.6K | ﹤0.01% | 2080 |
|
|
2023
Q4 | $895K | Buy |
352,265
+32,081
| +10% | +$62.8K | ﹤0.01% | 2117 |
|
|
2023
Q3 | $656K | Sell |
320,184
-108,089
| -25% | -$227K | ﹤0.01% | 2284 |
|
|
2023
Q2 | $1.07M | Buy |
428,273
+110,818
| +35% | +$288K | ﹤0.01% | 2152 |
|
|
2023
Q1 | $981K | Sell |
317,455
-2,338
| -0.7% | -$6.59K | ﹤0.01% | 2058 |
|
|
2022
Q4 | $793K | Sell |
319,793
-210
| -0.1% | -$502 | ﹤0.01% | 2329 |
|
|
2022
Q3 | $707 | Sell |
320,003
-8,459
| -3% | -$19.9K | ﹤0.01% | 2370 |
|
|
2022
Q2 | $869 | Buy |
328,462
+9,882
| +3% | +$25.3K | ﹤0.01% | 2399 |
|
|
2022
Q1 | $953K | Buy |
318,580
+81,722
| +35% | +$250K | ﹤0.01% | 2381 |
|
|
2021
Q4 | $921K | Buy |
236,858
+24,297
| +11% | +$94.4K | ﹤0.01% | 1996 |
|
|
2021
Q3 | $910K | Sell |
212,561
-39,480
| -16% | -$132K | ﹤0.01% | 2554 |
|
|
2021
Q2 | $796K | Sell |
252,041
-16,347
| -6% | -$50.6K | ﹤0.01% | 2617 |
|
|
2021
Q1 | $883K | Sell |
268,388
-107,125
| -29% | -$413K | ﹤0.01% | 2289 |
|
|
2020
Q4 | $1.62M | Sell |
375,513
-30,502
| -8% | -$107K | ﹤0.01% | 1938 |
|
|
2020
Q3 | $1.25M | Sell |
406,015
-59,951
| -13% | -$182K | ﹤0.01% | 1872 |
|
|
2020
Q2 | $867K | Sell |
465,966
-99,556
| -18% | -$163K | ﹤0.01% | 2000 |
|
|
2020
Q1 | $566K | Sell |
565,522
-151,728
| -21% | -$410K | ﹤0.01% | 1924 |
|
|
2019
Q4 | $1.99M | Sell |
717,250
-289,965
| -29% | -$469K | ﹤0.01% | 1879 |
|
|
2019
Q3 | $1.54M | Sell |
1,007,215
-41,791
| -4% | -$72K | ﹤0.01% | 1855 |
|
|
2019
Q2 | $2.18M | Buy |
1,049,006
+69,882
| +7% | +$179K | ﹤0.01% | 1638 |
|
|
2019
Q1 | $3.5M | Buy |
979,124
+11,520
| +1% | +$44.2K | ﹤0.01% | 1354 |
|
|
2018
Q4 | $3.71M | Buy |
967,604
+57,398
| +6% | +$283K | ﹤0.01% | 1224 |
|
|
2018
Q3 | $8.6M | Sell |
910,206
-34,558
| -4% | -$343K | 0.01% | 950 |
|
|
2018
Q2 | $6.9M | Buy |
944,764
+62,341
| +7% | +$371K | 0.01% | 1026 |
|
|
2018
Q1 | $4.41M | Buy |
882,423
+19,026
| +2% | +$101K | ﹤0.01% | 1197 |
|
|
2017
Q4 | $4.36M | Buy |
863,397
+9,468
| +1% | +$55.5K | ﹤0.01% | 1194 |
|
|
2017
Q3 | $5.29M | Sell |
853,929
-20,325
| -2% | -$86.9K | ﹤0.01% | 1148 |
|
|
2017
Q2 | $3.15M | Buy |
874,254
+16,535
| +2% | +$56.9K | ﹤0.01% | 1398 |
|
|
2017
Q1 | $2.79M | Sell |
857,719
-27,478
| -3% | -$76.2K | ﹤0.01% | 1353 |
|
|
2016
Q4 | $2.35M | Buy |
885,197
+23,644
| +3% | +$68.8K | ﹤0.01% | 1461 |
|
|
2016
Q3 | $2.96M | Buy |
861,553
+50,768
| +6% | +$198K | ﹤0.01% | 1315 |
|
|
2016
Q2 | $2.82M | Buy |
810,785
+15,450
| +2% | +$65.4K | ﹤0.01% | 1332 |
|
|
2016
Q1 | $3.29M | Buy |
795,335
+25,565
| +3% | +$91.3K | ﹤0.01% | 1198 |
|
|
2015
Q4 | $3.42M | Buy |
+769,770
| New | +$4.22M | ﹤0.01% | 1145 |
|
|
2015
Q3 | – | Sell |
-775,803
| Closed | -$9.2M | – | 3963 |
|
|
2015
Q2 | $9.2M | Buy |
775,803
+21,080
| +3% | +$321K | 0.01% | 848 |
|
|
2015
Q1 | $13.2M | Buy |
754,723
+26,828
| +4% | +$550K | 0.02% | 685 |
|
|
2014
Q4 | $11M | Sell |
727,895
-93,425
| -11% | -$1.61M | 0.01% | 742 |
|
|
2014
Q3 | $17.4M | Sell |
821,320
-3,276
| -0.4% | -$53.5K | 0.02% | 558 |
|
|
2014
Q2 | $10.8M | Buy |
824,596
+21,784
| +3% | +$309K | 0.01% | 775 |
|
|
2014
Q1 | $17.3M | Buy |
802,812
+53,213
| +7% | +$956K | 0.02% | 468 |
|
|
2013
Q4 | $5.97M | Sell |
749,599
-49,270
| -6% | -$410K | 0.01% | 787 |
|
|
2013
Q3 | $5.55M | Buy |
798,869
+9,041
| +1% | +$49.8K | 0.01% | 741 |
|
|
2013
Q2 | $3.71M | Buy |
+789,828
| New | +$3.74M | 0.01% | 843 |
|
Other funds holding ABUS
TSC
WCM
BCP
Bank of Montreal's ABUS Position: Q2 2026 in Review
Bank of Montreal reduced its Arbutus Biopharma (ABUS) stake by 0.62% in Q2 2026, selling an estimated $21.2K and leaving 777,938 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1481.
Bank of Montreal first reported a position in ABUS in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.4M in Q3 2014. 163 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.
- Bank of Montreal held 777,938 shares of Arbutus Biopharma worth $3.73M as of Q2 2026.
- Bank of Montreal sold 4,825 Arbutus Biopharma shares in Q2 2026, an estimated $21.2K.
- Arbutus Biopharma made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1481 holding.
- Bank of Montreal first reported a position in Arbutus Biopharma in Q2 2013 and has held it in 52 quarters since.
- Bank of Montreal's Arbutus Biopharma position peaked at $17.4M in Q3 2014.
- 163 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.